# Eos Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eos-biotechnology

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Total disclosed funding: $9.5M
- Latest round: Series A (Jul 1, 1997)
- Investors on record: 5

## About

Eos Biotechnology, Inc. is a functional genomics company developing therapeutic antibodies for cancer, angiogenesis, and inflammation.

## Funding rounds

- Series A, Jul 1, 1997, $9.5M — Rothschild Ventures, CW Group, Venrock, Bay City Capital, Techno-Venture Co. Ltd

## Investors

- Rothschild Ventures (https://capitalatlas.ai/funds/rothschild-ventures) — Series A
- CW Group (https://capitalatlas.ai/funds/cw-group) — Series A
- Venrock (https://capitalatlas.ai/funds/venrock) — Series A
- Bay City Capital (https://capitalatlas.ai/funds/bay-city-capital) — Series A
- Techno-Venture Co. Ltd — Series A